73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Bendamustine prior to CAR T-cell therapy in patients with refractory large B-cell lymphoma: Poorer treatment outcomes

Bendamustine prior to CAR T-cell therapy in patients with refractory large B-cell lymphoma: Poorer treatment outcomes

byVall d'Hebron Institute of OncologyCredit: Pixabay/CC0 Public DomainTreatment with bendamustine prior to CAR T-cell therapy in patients with refractory large B-cell lymphoma associates wit

Bendamustine prior to CAR T-cell therapy in patients with refractory large B-cell lymphoma: Poorer treatment outcomes

byVall d'Hebron Institute of OncologyCredit: Pixabay/CC0 Public DomainTreatment with bendamustine prior to CAR T-cell therapy in patients with refractory large B-cell lymphoma associates wit
Discovery adds to evidence that some children are predisposed to develop leukemia

Discovery adds to evidence that some children are predisposed to develop leukemia

by St. Jude Children's Research HospitalCharles Mullighan, MBBS, M.D., Michelle Churchman Ph.D., Max Qian PhD, Jun Yang Ph.D. Credit: St. Jude Children's Research Hospital / Seth DixonSt.

Discovery adds to evidence that some children are predisposed to develop leukemia

by St. Jude Children's Research HospitalCharles Mullighan, MBBS, M.D., Michelle Churchman Ph.D., Max Qian PhD, Jun Yang Ph.D. Credit: St. Jude Children's Research Hospital / Seth DixonSt.
New study explores challenges and opportunities for cancer research

New study explores challenges and opportunities for cancer research

by Richard Harth,Arizona State UniversityA recent review by Carlo Maley, a researcher at Arizona State University, and Lucie Laplane from the University of Paris Pantheon-Sorbonne critiques the

New study explores challenges and opportunities for cancer research

by Richard Harth,Arizona State UniversityA recent review by Carlo Maley, a researcher at Arizona State University, and Lucie Laplane from the University of Paris Pantheon-Sorbonne critiques the
Aumolertinib shows improved progression-free survival in stage III non-small cell lung cancer

Aumolertinib shows improved progression-free survival in stage III non-small cell lung cancer

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe epidermal growth factor receptor tyrosine kinase inhibitor aumolertinib demonstrated improved progression-

Aumolertinib shows improved progression-free survival in stage III non-small cell lung cancer

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe epidermal growth factor receptor tyrosine kinase inhibitor aumolertinib demonstrated improved progression-
Team successfully generates mouse models for two subtypes of multiple myeloma

Team successfully generates mouse models for two subtypes of multiple myeloma

by Catarina Pietschmann,Max Delbrück Center for Molecular MedicineLeft: Normal bone marrow in the control animals with stained myeloid cells. Right: Bone marrow in the transgenic animals with pl

Team successfully generates mouse models for two subtypes of multiple myeloma

by Catarina Pietschmann,Max Delbrück Center for Molecular MedicineLeft: Normal bone marrow in the control animals with stained myeloid cells. Right: Bone marrow in the transgenic animals with pl
Exome sequencing identifies those with cancer predisposition syndromes missed by current screening guidelines

Exome sequencing identifies those with cancer predisposition syndromes missed by current screening guidelines

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainAmong individuals who consented to whole-exome sequencing and were identified as carriers of predisposition genes for h

Exome sequencing identifies those with cancer predisposition syndromes missed by current screening guidelines

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainAmong individuals who consented to whole-exome sequencing and were identified as carriers of predisposition genes for h
Genetically modified herpes virus delivers one-two punch against advanced cancers

Genetically modified herpes virus delivers one-two punch against advanced cancers

byInstitute of Cancer ResearchCarcinoma of salivary gland. Credit: Nephron, CC BY-SA 4.0, via Wikimedia CommonsA new genetically engineered virus has delivered a one-two punch against advanced c

Genetically modified herpes virus delivers one-two punch against advanced cancers

byInstitute of Cancer ResearchCarcinoma of salivary gland. Credit: Nephron, CC BY-SA 4.0, via Wikimedia CommonsA new genetically engineered virus has delivered a one-two punch against advanced c
Researchers synthesize chimeric peptide that elicits antitumor activity for cancer immunotherapy

Researchers synthesize chimeric peptide that elicits antitumor activity for cancer immunotherapy

by Science China PressThepeptide Pal-DMPOP consists a peptide inhibitor of CD47/SIRPα, a D-peptide inhibitor of PD-1/PD-L1, and a palmitic acid tail conjugated at its N-terminal through a P

Researchers synthesize chimeric peptide that elicits antitumor activity for cancer immunotherapy

by Science China PressThepeptide Pal-DMPOP consists a peptide inhibitor of CD47/SIRPα, a D-peptide inhibitor of PD-1/PD-L1, and a palmitic acid tail conjugated at its N-terminal through a P
Genomic features of AML in patients over age 60 can predict success of stem cell transplant

Genomic features of AML in patients over age 60 can predict success of stem cell transplant

by Dana-Farber Cancer InstituteR. Coleman Lindsley, MD, PhD. Credit: Dana-Farber Cancer InstituteFor older patients with acute myeloid leukemia (AML), the prospects for success of a stem cell tra

Genomic features of AML in patients over age 60 can predict success of stem cell transplant

by Dana-Farber Cancer InstituteR. Coleman Lindsley, MD, PhD. Credit: Dana-Farber Cancer InstituteFor older patients with acute myeloid leukemia (AML), the prospects for success of a stem cell tra
Early-stage cancer diagnoses decreased sharply in the US during first year of COVID-19 pandemic

Early-stage cancer diagnoses decreased sharply in the US during first year of COVID-19 pandemic

by American Cancer SocietyCOVID-19 and Cancer. Credit: American Cancer SocietyA new study from researchers at the American Cancer Society (ACS) found monthly adult cancer diagnoses decreased by h

Early-stage cancer diagnoses decreased sharply in the US during first year of COVID-19 pandemic

by American Cancer SocietyCOVID-19 and Cancer. Credit: American Cancer SocietyA new study from researchers at the American Cancer Society (ACS) found monthly adult cancer diagnoses decreased by h
Study reveals CREB3's role in hepatocellular carcinoma suppression via AKT signaling

Study reveals CREB3's role in hepatocellular carcinoma suppression via AKT signaling

by Sichuan International Medical Exchange and Promotion AssociationExpression of CREB3 is decreased in HCC tissues and correlated with better clinical outcome. (A) mRNA expression of CREB3 in HCC tiss

Study reveals CREB3's role in hepatocellular carcinoma suppression via AKT signaling

by Sichuan International Medical Exchange and Promotion AssociationExpression of CREB3 is decreased in HCC tissues and correlated with better clinical outcome. (A) mRNA expression of CREB3 in HCC tiss
Researchers study cost-effectiveness of rectal cancer treatments

Researchers study cost-effectiveness of rectal cancer treatments

by Duane Bates,University of California, Los AngelesUCLA radiation therapists review a patient’s plan before setting the patient up for treatment. Credit: University of California, Los AngelesCo

Researchers study cost-effectiveness of rectal cancer treatments

by Duane Bates,University of California, Los AngelesUCLA radiation therapists review a patient’s plan before setting the patient up for treatment. Credit: University of California, Los AngelesCo